Joy Behar’s recent remarks on “The View” have drawn scrutiny after she claimed President Trump’s government prescription drug program, TrumpRx.gov, would lead to a death sentence for the public. During her segment, Behar stated that the initiative caused the phrase, “we’re all going to die.”
This claim has been met with criticism from families who face difficult choices between groceries and life-saving medications for their children.
TrumpRx is designed to reduce prescription drug costs by eliminating middlemen and implementing competitive pricing. The program has delivered significant savings for families across various medical conditions.
For instance, Regeneron’s gene therapy Otarmeni, which treats a rare genetic form of deafness, is now available at no cost to American families under TrumpRx. Families dealing with pediatric arthritis or Crohn’s disease can access Humira for approximately $950 per dose instead of nearly $7,000.
Fertility drugs such as Gonal-F have dropped from hundreds of dollars to as little as $168 per pen. Inhalers for chronic obstructive pulmonary disease and asthma have seen dramatic price reductions: Bevespi Aerosphere fell from $458 to $51, Airsupra dropped from $504 to $201, and Trulicity decreased from $987 to $389.
An ABC host named Hostin clarified that President Trump does not profit from TrumpRx. “He is not doing this out of the goodness of his heart,” Hostin stated. “He’s doing this to make money.”
However, the president receives no royalties, fees, or equity from the program. TrumpRx operates as a government-run initiative accessible through trumprx.gov.
A pediatric registered nurse and whistleblower, Vanessa Sivadge, who leads the Protect Texas Children organization, has emphasized the importance of such programs in healthcare access.
The program is not perfect, but it provides tangible relief for families who previously could not afford critical medications without skipping doses or facing financial ruin.
